Last updated: 4/28/2023
MycoMedica Life Sciences is a Washington-based life sciences firm that develops and commercializes therapeutics for the treatment of psychiatric and neurological disorders.
CEO
Paul Stamets
Employee count
5
Industry
Life Sciences
Annual revenue
$23K
Founding date
2021
Total funding
$89.9M
Headquarters
Shelton, Washington, USA
Status
Independent Company
Market competitors
CEO
Barry E. Greene
Employee count
690
Industry
Biotechnology
Annual revenue
$7.7M
Founding date
2010
Total funding
$843M
Headquarters
Cambridge, Massachusetts, USA
Status
Independent Company
CEO
Mihael H. Polymeropoulos
Employee count
280
Industry
Pharmaceuticals
Annual revenue
$258M
Founding date
2003
Total funding
$353.3M
Headquarters
Washington, District of Columbia, USA
Status
Independent Company
CEO
Herriot Tabuteau
Employee count
380
Industry
Biotechnology
Annual revenue
$50M
Founding date
2012
Total funding
$604.7M
Headquarters
New York, New York, USA
Status
Independent Company
CEO
Antony Loebel
Employee count
1620
Industry
Pharmaceuticals
Annual revenue
$600M
Founding date
2010
Total funding
$0
Headquarters
Marlborough, Massachusetts, USA
Status
Subsidiary
CEO
Bill Meury
Employee count
210
Industry
Biotechnology
Annual revenue
$11M
Founding date
2009
Total funding
$2B
Headquarters
Boston, Massachusetts, USA
Status
Independent Company
CEO
Name surname
Employee count
5000
Industry
Industry name
Annual revenue
5000
Founding date
1990
Total funding
484884
Headquarters
New York, New York, USA
Status
-
Unlock more company data and insights for MycoMedica Life Sciences, PBC
Funding
| Amount | Funding date | Round | Number of investors | Investors |
|---|---|---|---|---|
| $22M | May 2021 | Equity | - | - |
| $7.4M | May 2021 | Equity | - | - |
| $60M | May 2022 | Venture Round | - | - |
| $400K | Jan 15, 2019 | Round 2 | 3 | investor 1, investor 2, investor 3 |